Neonc Technologies Holdings, Inc.
NASDAQ:NTHIBiotechnology
+$0.14 today
- Market cap
- $124.92M
- Beta
- 0.29
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$1.66
Volume 0.26M
Average 0.08M
Returns on capital
Neonc Technologies Holdings, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
355.0%
avg 355.0%
ROIC
519.7%
avg 519.7%
ROA
-2200.9%
avg -2200.9%
Analysis
ROIC is currently the strongest return metric at 519.7% versus its period average of 519.7%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Thomas C. Chen | Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman | USD 212K | 61 | 29.52K | 0.15% |
Keithly A. Garnett | Chief Financial Officer | USD 179K | 51 | — | — |
Josh Neman-Ebrahim | Chief Clinical Officer | USD 165K | 48 | — | — |
Amir Farrokh Heshmatpour | President, Chief Executive Officer, Executive Chairman & Secretary | — | 59 | — | — |
David Choi | Chief Accounting Officer | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 10, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
30
$1.81M
Sells
0
$0.00
Net Transaction Value
+$1.81M
Net buying
Most Active
Heshmatpour Amir F
16 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Nov 13, 26Nov 13, 2026 | Heshmatpour Amir F Direct | Buy | $150.5K$150,501.00 |
| Nov 11, 26Nov 11, 2026 | Heshmatpour Amir F Direct | Buy | $40K$40,000.00 |
| Nov 11, 26Nov 11, 2026 | Heshmatpour Amir F Direct | Buy | $44.9K$44,900.00 |
| Nov 10, 26Nov 10, 2026 | CHEN THOMAS C Indirect | Buy | $10K$10,001.64 |
| Nov 10, 26Nov 10, 2026 | Heshmatpour Amir F Direct | Buy | $209.6K$209,600.00 |
| Nov 9, 26Nov 9, 2026 | Heshmatpour Amir F Direct | Buy | $38.6K$38,600.00 |
| Nov 9, 26Nov 9, 2026 | CHEN THOMAS C Indirect | Buy | $10K$9,999.12 |
| Nov 6, 26Nov 6, 2026 | Heshmatpour Amir F Direct | Buy | $135.5K$135,500.00 |
| Nov 5, 26Nov 5, 2026 | Heshmatpour Amir F Direct | Buy | $95K$95,010.00 |
| Sep 15, 26Sep 15, 2026 | GARNETT KEITHLY Direct | Buy | $16.8K$16,809.00 |
1–10 of 30
Summary
Insiders reported 30 buys worth $1.81M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $1.81M. Heshmatpour Amir F was the most active insider with 16 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +392.0% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +392.0% (5yr), giving you a quick read on expected growth from here.
Competitors
Who does Neonc Technologies Holdings, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
No competitor data available.
Questions
Management questions
Common questions about NTHI's management, answered from reported figures.
Who manages NTHI?
Neonc Technologies Holdings, Inc. (NTHI) lists 5 active executives. The top listed executive is Josh Neman-Ebrahim, Chief Clinical Officer.
Are NTHI insiders buying or selling?
Recent insider activity shows net selling of $1.81M.
Continue the stock analysis
Jump to another research area for this company.